Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
María Dema, Herena Eixarch, Luisa María Villar, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 9, pp. 102893-102893
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study
Emilio Portaccio, Angelo Bellinvia, Mattia Fonderico, et al.
Brain (2022) Vol. 145, Iss. 8, pp. 2796-2805
Open Access | Times Cited: 90
Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis
Océane Perdaens, Vincent Van Pesch
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 40
Impact of aging on treatment considerations for multiple sclerosis patients
Gabrielle Macaron, Catherine Larochelle, Nathalie Arbour, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 28
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review
Nicola Capasso, Eleonora Virgilio, Antonio Covelli, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 27
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients
Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Disease Aggravation With Age in an Experimental Model of Multiple Sclerosis: Role of Immunosenescence
María Dema, Herena Eixarch, Arnau Hervera, et al.
Aging Cell (2025)
Open Access | Times Cited: 1
Age-Related Disability Outcomes After a First Demyelinating Event
Álvaro Cobo‐Calvo, Pere Carbonell‐Mirabent, Carmen Tur, et al.
Neurology (2025) Vol. 104, Iss. 4
Closed Access | Times Cited: 1
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases
Riccardo Nistri, Elena Barbuti, Virginia Rinaldi, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 49
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
Maria Chiara Buscarinu, Roberta Reniè, Emanuele Morena, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 38
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Carmen Tur, Anne‐Laure Dubessy, Susana Otero‐Romero, et al.
Multiple Sclerosis Journal (2022) Vol. 28, Iss. 9, pp. 1424-1456
Open Access | Times Cited: 34
Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis
Brandi Vollmer, Andrew B. Wolf, Stefan Sillau, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 33
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age
Leah Zuroff, Ayman Rezk, Koji Shinoda, et al.
EBioMedicine (2022) Vol. 82, pp. 104179-104179
Open Access | Times Cited: 32
Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration
Smathorn Thakolwiboon, Elizabeth Mills, Jennifer Yang, et al.
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 21
Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: an insight into the role of the AMPK/SIRT1 pathway
Mohamed A. Sadek, Mostafa A. Rabie, Nesrine S. El Sayed, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1499-1518
Open Access | Times Cited: 18
The need for a strategic therapeutic approach: multiple sclerosis in check
Hernán Inojosa, Undine Proschmann, Katja Akgün, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13
Open Access | Times Cited: 25
The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis
Stanley Cohan, Ralph H. B. Benedict, Bruce Cree, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 703-719
Open Access | Times Cited: 24
CD4+ T-Cell Senescence in Neurodegenerative Disease: Pathogenesis and Potential Therapeutic Targets
Yan Gao, Yaoping Lu, Xiaojing Liang, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 749-749
Open Access | Times Cited: 5
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
Rocco Capuano, Alvino Bisecco, Miriana Conte, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 60, pp. 103724-103724
Open Access | Times Cited: 22
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review
Fardin Nabizadeh, Elham Ramezannezhad, Kimia Kazemzadeh, et al.
Journal of Clinical Neuroscience (2022) Vol. 104, pp. 118-125
Open Access | Times Cited: 22
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
Ana Zabalza, Georgina Arrambide, Paula Tagliani, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 2
Open Access | Times Cited: 20
Reliable Hallmarks and Biomarkers of Senescent Lymphocytes
Yuliya S. Martyshkina, Valeriy Tereshchenko, Daria A. Bogdanova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15653-15653
Open Access | Times Cited: 12
Senescent T Cells in Age-Related Diseases
Pei-Jie Yu, Mei Zhou, Yan Liu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 4
Management of multiple sclerosis in older adults: review of current evidence and future perspectives
Kimberly DiMauro, Carol Swetlik, Jeffrey A. Cohen
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3794-3805
Open Access | Times Cited: 4
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Elizabeth A. Maupin, Katrina L. Adams
Journal of Neurochemistry (2025) Vol. 169, Iss. 1
Open Access
T cell aging and exhaustion: Mechanisms and clinical implications
Weiqi Zhang, Dejun Kong, Xiaohan Zhang, et al.
Clinical Immunology (2025) Vol. 275, pp. 110486-110486
Closed Access
Page 1 - Next Page

Scroll to top